Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

Featured article

The article looks at the top 50 companies overall and discusses the top ten companies in detail. The big movers and shakers of the year are also highlighted and predictions for 2014 are made. More


Featured partnering deals

BMS and Ono Pharma have signed pharma alliance

July 25, 2014 : big pharma, Bristol-Myers Squibb, pharma alliances

Bristol-Myers Squibb and Ono Pharmaceutical have signed a strategic pharma alliance collaboration agreement to jointly develop and commercialize multiple immunotherapies.

more »

ArmaGen signs a pharma licensing deal with Shire

July 24, 2014 : big pharma, partnering, pharma licensing, shire

Shire and ArmaGen announced a worldwide pharma licensing and collaboration agreement for AGT-182. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Yibai Pharma has acquired Tianjin Horus

July 22, 2014 : acquisition, M&A, pharma

China-based, Guizhou Yibai Pharma will pay $128 million to acquire Tianjin Horus C&K Pharmaceutical. more »

M&A news: AbbVie has finally won over Shire

July 21, 2014 : AbbVie, acquisition, M&A, shire

Shire has finally agreed for an m&a agreement with AbbVie for $54 billion. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Remiges raises $30 million in venture capital financing

July 24, 2014 : financing, financings, pharma

Taiho Pharmaceutical announced that the company will be investing US$30 million in Remiges BioPharma Fund, a newly formed biotech venture capital financing. more »

Sofinnova closed $500 million in fundraising financing

July 24, 2014 : big pharma, financing, financings

Sofinnova Ventures announced the closing of Sofinnova Venture Partners IX, L.P. at the hard cap of $500 million and in excess of the initial financing target of $425 million. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Biotech rumour mill has it that Siemens plans for a spin off

July 15, 2014 : dealtalk, spin-out

Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division’s IT unit, which could be worth more than $1 billion. more »

Abbvie chases Shire again

July 1, 2014 : Abbott, AbbVie, acquisition, M&A

The boss of US drug-maker AbbVie is flying into London this week to court Shire’s shareholders and try to convince them of the merits of a potential takeover. more »

 More dealtalk

Featured reports

Licensing Terms and Agreements

Publication date: July 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

Infectious Vaccines Partnering Terms and Agreements

Publication date: June 2014

Antibiotics Partnering Terms and Agreements

Publication date: June 2014

Cancer Vaccine Partnering Terms and Agreements

Publication date: May 2014

Cancer Diagnostics Partnering Terms and Agreements

Publication date: May 2014

Gene Therapy Partnering Terms and Agreements

Publication date: May 2014

 

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
ca300x150gif
RSS Feed Linked In Twitter

Latest Tweets

ca300x150gif
bpa14banner300x150jpg
beu14banner300x150jpg